Trials / Conditions / Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
6 registered clinical trials studyying Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing NCT01588015 | City of Hope Medical Center | Phase 1 |
| Completed | Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma NCT01535924 | Beth Christian | Phase 1 / Phase 2 |
| Completed | A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma NCT01460940 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Completed | Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Re NCT00381940 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma NCT00288067 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma NCT00132028 | National Cancer Institute (NCI) | Phase 2 |